The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

16 May 2022 07:00

RNS Number : 5278L
Lekoil Limited
16 May 2022
 

16 May 2022

Lekoil Limited

("LEKOIL" or the "Company")

Notice of application for admission to the Aquis Stock Exchange and Cancellation of Admission to trading on AIM

LEKOIL (AIM: LEK), announces that it has applied for admission of its Ordinary Shares to trading on the Access segment of the AQSE Growth Market operated by the Aquis Stock Exchange (AQSE). It is expected that admission will occur on 18 May 2022 and that trading will commence on AQSE as soon as the audited accounts for the Company are released to the market, expected to be by the end of June 2022.

 

The Company's Ordinary Shares have been suspended from trading on AIM since October 2021. Pursuant to AIM Rule 41, admission of the Company's shares to trading on AIM will be cancelled with effect from 7.00 a.m. on 18 May 2022 with the Company's shares being admitted to trading on the AQSE Growth Market from this time.

Moving from AIM to AQSE will not affect a shareholder's legal or beneficial right to his or her shares. Shareholders are not required to take any action at this stage.

 

Anthony Hawkins, Interim Executive Chairman, commented:

"The Board of the Company considers AQSE to be a suitable exchange to provide for the continued listing of its shares.

The Board is of the view that the Company's primary activity is now the recovery of its investment through litigation against the Lekoil Nigeria group and Mr. Akinyanmi. This characterisation will allow the Company to fulfil its disclosure obligations to the AQSE market, noting that a successful recovery of the intercompany debts due to the Company will be the primary source of value for shareholders (with minimal value attributable to the day-to-day operational activities of Lekoil Nigeria).

With respect to the suspension of the Company's shares from trading on AQSE, the Company has a clear understanding as to what is required to restore trading in the Company's shares on AQSE and we are diligently working through that plan. We will update our shareholders on this matter as soon as is practicable.

In selecting the AQSE Growth Market, the Board was keen to provide shareholders with the services of a regulated SME Growth market and a trading facility while it pursues its litigation assets, and its strategy unfolds."

 

With effect from the cancellation of the admission of the Company's shares to trading on AIM SP Angel Corporate Finance LLP will cease to act as Nominated Adviser and joint broker to the Company.

 

The Company's shares will continue to be registered with the existing ISIN number KYG5462G1073 and SEDOL number B9FFQF9. The Company's ticker symbol will continue to be LEK.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

For further information, please visit www.lekoilplc.com or contact:

Lekoil Limited

Anthony Hawkins

 

info@lekoilplc.com

SP Angel Corporate Finance LLP (AIM Nominated Adviser and Joint Broker)

Jeff Keating / Stuart Gledhill

 

+44 20 3470 0470

First Sentinel Corporate Finance Limited (AQSE Corporate Adviser)

Brian Stockbridge

 

+44 20 3989 2200

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030

Camarco (Financial PR Advisor)

Billy Clegg / Owen Roberts / Violet Wilson

+44 20 3757 4983

  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAAMLTMTIBMAT
Date   Source Headline
10th Sep 20214:13 pmRNSHolding(s) in Company
10th Sep 202112:47 pmRNSDirector Loan - Update
8th Sep 202112:42 pmRNSCorporate update
2nd Sep 202112:17 pmRNSConvertible Facility Agreement
2nd Sep 20219:05 amRNSSecond Price Monitoring Extn
2nd Sep 20219:00 amRNSPrice Monitoring Extension
2nd Sep 20217:00 amRNSCorporate & Operational Update
1st Sep 20214:40 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20212:05 pmRNSSecond Price Monitoring Extn
1st Sep 20212:00 pmRNSPrice Monitoring Extension
1st Sep 202111:59 amRNSHolding(s) in Company
31st Aug 20214:40 pmRNSSecond Price Monitoring Extn
31st Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 202111:06 amRNSSecond Price Monitoring Extn
10th Aug 202111:00 amRNSPrice Monitoring Extension
5th Jul 20214:40 pmRNSSecond Price Monitoring Extn
5th Jul 20214:35 pmRNSPrice Monitoring Extension
5th Jul 20212:06 pmRNSSecond Price Monitoring Extn
5th Jul 20212:00 pmRNSPrice Monitoring Extension
2nd Jul 20214:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20212:05 pmRNSSecond Price Monitoring Extn
2nd Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jun 20217:00 amRNSChange of website address
21st Jun 20213:30 pmRNSResignation of CFO
18th Jun 202112:53 pmRNSDirectorate Change
17th Jun 20217:00 amRNSDelay in publication of Annual Results for 2020
10th Jun 20217:00 amRNSCorporate Update
3rd Jun 20217:00 amRNSDirectorate Change
17th May 20217:00 amRNSAward of Options
20th Apr 20217:07 amRNSDirectorate Change
15th Apr 20218:15 amRNSDirectorate Change
26th Mar 20217:00 amRNSTrading and operational update
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
10th Mar 20211:45 pmRNSDirector Loan - Update
26th Feb 20217:00 amRNSTR-1: notification of major holdings
24th Feb 20217:00 amRNSRe Cost and Revenue Sharing Agreement for OPL 310
4th Feb 20214:40 pmRNSSecond Price Monitoring Extn
4th Feb 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSJoint Broker Appointment
11th Jan 20217:00 amRNSAppointment of Chairman
8th Jan 202112:28 pmRNSResult of EGM
8th Jan 20217:00 amRNSRE Extraordinary General Meeting
7th Jan 20211:20 pmRNSResponse to Press Speculation
31st Dec 202012:43 pmRNSJoint Broker Resignation
29th Dec 20202:06 pmRNSSecond Price Monitoring Extn
29th Dec 20202:01 pmRNSPrice Monitoring Extension
22nd Dec 20206:05 pmRNSAppointment of Nominated Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.